BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18286567)

  • 21. Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth.
    Xie Q; Gan L; Wang J; Wilson I; Li L
    Mol Immunol; 2007 Jul; 44(14):3453-61. PubMed ID: 17477969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of IL-1 Receptor-Associated Kinase-4 Leads to Defective Th1 Cell Responses and Renders Mice Susceptible to Mycobacterial Infection.
    Marinho FV; Fahel JS; Scanga CA; Gomes MT; Guimarães G; Carvalho GR; Morales SV; Báfica A; Oliveira SC
    J Immunol; 2016 Sep; 197(5):1852-63. PubMed ID: 27439514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling.
    Kawagoe T; Sato S; Jung A; Yamamoto M; Matsui K; Kato H; Uematsu S; Takeuchi O; Akira S
    J Exp Med; 2007 May; 204(5):1013-24. PubMed ID: 17485511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRAK-4-dependent degradation of IRAK-1 is a negative feedback signal for TLR-mediated NF-kappaB activation.
    Kubo-Murai M; Hazeki K; Nigorikawa K; Omoto T; Inoue N; Hazeki O
    J Biochem; 2008 Mar; 143(3):295-302. PubMed ID: 18079163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection.
    Oliveira FS; Carvalho NB; Brandão AP; Gomes MT; de Almeida LA; Oliveira SC
    Infect Immun; 2011 Nov; 79(11):4688-95. PubMed ID: 21844234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in mice.
    Lykken JM; DiLillo DJ; Weimer ET; Roser-Page S; Heise MT; Grayson JM; Weitzmann MN; Tedder TF
    J Immunol; 2014 Jul; 193(2):746-56. PubMed ID: 24928986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
    Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
    J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique mechanism for innate cytokine promotion of T cell responses to viral infections.
    Pien GC; Nguyen KB; Malmgaard L; Satoskar AR; Biron CA
    J Immunol; 2002 Nov; 169(10):5827-37. PubMed ID: 12421964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells.
    Nembrini C; Abel B; Kopf M; Marsland BJ
    J Immunol; 2006 Jun; 176(12):7180-8. PubMed ID: 16751361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wear particles promote endotoxin tolerance in macrophages by inducing interleukin-1 receptor-associated kinase-M expression.
    Zhang Y; Yu S; Xiao J; Hou C; Li Z; Zhang Z; Zhai Q; Lehto M; Konttinen YT; Sheng P
    J Biomed Mater Res A; 2013 Mar; 101(3):733-9. PubMed ID: 22941946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
    Bättig P; Saudan P; Storni T; Gallimore A; Bachmann MF
    Microbes Infect; 2005 Apr; 7(4):729-37. PubMed ID: 15857805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5.
    Zhang Y; Blattman JN; Kennedy NJ; Duong J; Nguyen T; Wang Y; Davis RJ; Greenberg PD; Flavell RA; Dong C
    Nature; 2004 Aug; 430(7001):793-7. PubMed ID: 15306813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation.
    Shaabani N; Khairnar V; Duhan V; Zhou F; Tur RF; Häussinger D; Recher M; Tumanov AV; Hardt C; Pinschewer D; Christen U; Lang PA; Honke N; Lang KS
    J Autoimmun; 2016 Feb; 67():82-89. PubMed ID: 26553386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells.
    Matter MS; Hilmenyuk T; Claus C; Marone R; Schürch C; Tinguely M; Terracciano L; Luther SA; Ochsenbein AF
    PLoS One; 2011; 6(9):e24772. PubMed ID: 21966366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC.
    Suzuki N; Suzuki S; Eriksson U; Hara H; Mirtosis C; Chen NJ; Wada T; Bouchard D; Hwang I; Takeda K; Fujita T; Der S; Penninger JM; Akira S; Saito T; Yeh WC
    J Immunol; 2003 Dec; 171(11):6065-71. PubMed ID: 14634120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes.
    Julian MW; Strange HR; Ballinger MN; Hotchkiss RS; Papenfuss TL; Crouser ED
    PLoS One; 2015; 10(7):e0132921. PubMed ID: 26218271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis.
    Soares-Schanoski A; Gómez-Piña V; del Fresno C; Rodríguez-Rojas A; García F; Glaría A; Sánchez M; Vallejo-Cremades MT; Baos R; Fuentes-Prior P; Arnalich F; López-Collazo E
    J Leukoc Biol; 2007 Sep; 82(3):700-9. PubMed ID: 17576820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression.
    Koziczak-Holbro M; Joyce C; Glück A; Kinzel B; Müller M; Tschopp C; Mathison JC; Davis CN; Gram H
    J Biol Chem; 2007 May; 282(18):13552-60. PubMed ID: 17337443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo modulation of T cell responses and protective immunity by TCR antagonism during infection.
    Lau LL; Jiang J; Shen H
    J Immunol; 2005 Jun; 174(12):7970-6. PubMed ID: 15944303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.